Where Will Pfizer Stock Be in 10 Years?

on MSN ago, source:

But could that be a mistake, and could Pfizer return to glory in 10 years and prove to be a great buy again? Here's where the ...

Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion

2y ago, source: pharmaphorum

The company has agreed a $2.3 billion deal to buy Canadian biotech Trillium Therapeutics and its two lead candidates – TTI-622 and TTI-621 – which both act on signal-regulatory protein alpha ...

Trillium Therapeutics (TSX:TRIL): A Pharma Stock With Huge Upside Potential

2y ago, source: The Motley Fool Canada

Trillium Therapeutics (TSX:TRIL)(NASDAQ:TRIL) is a Canadian pharmaceutical stock that has massive upside potential and should be on your radar right now. The clinical-stage immuno-oncology ...

Anticancer Therapies – News and Features

6mon ago, source: technologynetworks

Epic Sciences, Inc. and Avera Medical Group have announced a collaboration on feasibility studies to better understand the effectiveness of personalized cancer treatments as part of novel ovarian and ...

Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing

27d ago, source: ADVFN

today announced that it has signed a definitive debenture purchase and merger agreement with Trillium Therapeutics Inc. ("Trillium") and its debenture holders, who also comprise the preferred ...

VIRX Viracta Therapeutics, Inc.

6h ago, source: Seeking Alpha

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product ...

DSGN Design Therapeutics, Inc.

9h ago, source: Seeking Alpha

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Intellia Therapeutics Inc NTLA

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aquestive Therapeutics, Inc. (AQST)

1d ago, source: Yahoo Finance

WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company ...

Revance Therapeutics, Inc. (RVNC)

1d ago, source: Yahoo Finance

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Aclaris Therapeutics Inc ACRS

5d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Fate Therapeutics, Inc.

17d ago, source: CNN

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno ...